Douglas Cdmo

City : Auckland

State :

Country/Area : New Zealand

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2025-05-30

Product
Web Link

02 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : Voluntary Action Indicated

Inspection End Date : 2021-06-15

City : Warminster

State : Pennsylvania

Country/Area : U.S.A

Zip : 18974

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2021-06-15

Product
Web Link

03 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : Voluntary Action Indicated

Inspection End Date : 2021-06-15

City : Warminster

State : Pennsylvania

Country/Area : U.S.A

Zip : 18974

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2021-06-15

Product
Web Link

04 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-10-11

City : Auckland

State :

Country/Area : New Zealand

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-10-11

Product
Web Link

05 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-12-01

City : Auckland

State :

Country/Area : New Zealand

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-12-01

Product
Web Link

06 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : No Action Indicated

Inspection End Date : 2016-07-29

City : Auckland

State :

Country/Area : New Zealand

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2016-07-29

Product
Web Link

07 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : Voluntary Action Indicated

Inspection End Date : 2014-07-04

City : Auckland

State :

Country/Area : New Zealand

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2014-07-04

Product
Web Link

08 FDA Audited

USA

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

District Decision : No Action Indicated

Inspection End Date : 2011-05-31

City : Auckland

State :

Country/Area : New Zealand

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2011-05-31

Product
Web Link